The World Health Organization (WHO) recommends artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated malaria in children. For severe malaria, artesunate is recommended over quinine due to better efficacy and safety profiles. Dosage and duration of treatment should be carefully followed according to established guidelines to prevent resistance and ensure effectiveness.
